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Abstract
Ingestion of glucosinolates has previously been reported to improve endothelial function in spontaneously hypertensive
rats, possibly because of an increase in NO availability in the endothelium due to an attenuation of oxidative stress; in our
study we tried to see if this also would be the case in humans suffering from essential hypertension.
Methods: 40 hypertensive individuals without diabetes and with normal levels of cholesterol were examined. The
participants were randomized either to ingest 10 g dried broccoli sprouts, a natural donor of glucosinolates with high in
vitro antioxidative potential, for a 4 week period or to continue their ordinary diet and act as controls. Blood pressure,
endothelial function measured by flow mediated dilation (FMD) and blood samples were obtained from the participants
every other week and the content of glucosinolates was measured before and after the study. Measurements were blinded
to treatment allocation.
Results: In the interventional group overall FMD increased from 4% to 5.8% in the interventional group whereas in the
control group FMD was stable (4% at baseline and 3.9% at the end of the study). The change in FMD in the interventional
group was mainly due to a marked change in FMD in two participants while the other participants did not have marked
changes in FMD. The observed differences were not statistically significant. Likewise significant changes in blood pressure or
blood samples were not detected between or within groups. Diastolic blood pressure stayed essentially unchanged in both
groups, while the systolic blood pressure showed a small non significant decrease (9 mm Hg) in the interventional group
from a value of 153 mm Hg at start.
Conclusion: Daily ingestion of 10 g dried broccoli sprouts does not improve endothelial function in the presence of
hypertension in humans.
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Introduction
Oxidative stress is considered to play a important role in the
processes of cellular injury which ultimately leads to the develop-
ment of atherosclerosis.[1] However, clinical studies of antioxi-
dants directly administered as a supplement have shown no effects
of antioxidants on cardiovascular morbidity and mortality. [2]. An
attractive alternative could be to augment the naturally occurring
antioxidative defense.[3,4]
A group of substances which might have this effect are the
glucosinolates, substances naturally occurring in cruciferous plants;
the glucosinolates are precursors to isothiocyanates, of which
sulphoraphane is one of the most potent inducers of the expression
of phase-2-enzymes, in mammalian cells.[5,6,7].
Among the enzymes induced in vitro the gluthation-S-reductase
may be of particular interest since it is instrumental in recycling
gluthathion to its reduced state in the cell. In broccoli sprouts
younger than 4 days glucoraphanin[5] is abundant and when
ingested, glucoraphanin is converted to sulphoraphane. In vitro
studies have demonstrated the beneficial effects of glucosinolates on
mammalian cell lines[7]. Wuand colleagues demonstrated that daily
treatment of Stroke Prone Hypertensive rats with dried broccoli
sprouts after weaning attenuated the development of hypertension
and improved endothelial function of the carotid arteries.[8]
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12461We therefore decided to study whether the administration of
dried broccoli sprouts in patients with essential hypertension could
decrease blood pressure and increase flow mediated vasodila-
tion(FMD). We have focused on endothelial function since this
parameter previously has been demonstrated to be influenced by
the level of oxidative stress, and because it is a sensitive predictor
for oxidative stress as well as for the future development of
atherosclerosis.[9,10]
We hypothesized that an increase in flow mediated vasodilation
shooud be detectable in the interventonal group after four weeks of
treatment both if we used the participants as their own controls
and if we compared them to a control group. This was our
primary outcome.
Secondary outcomes in our study were measurement of blood
pressure and lipoproteins where we were interested in seeing if
the blood pressure would decrease during treatment and if
lipoproteins would show an increase in HDL as well as a decrease
in LDL.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Participants
Volunteers were enrolled in the study after advertising in local
newspapers for non smoking hypertensive individuals without
known diabetes or hypercholesterolemia. In- and Exclusion
criteria are listed in Table 1.
Ethics
The study was approved of the ethics committee for Copenha-
gen and Frederiksberg municipalities (no 01-257/04). Written
informed consent was obtained from all participants.
Intervention
Endothelial function was measured on each individual three
times, at start of treatment and twice during the four weeks of
treatment with an interval of two weeks. Blood samples for
erythrocyte content and inflammation, samples for lipids, blood
glucose and inflammation were taken at each visit. Furthermore
samples were obtained for analyzing the blood content of
glucosinolates and their metabolites. The purpose for measuring
the erythrocyte content blood glucose and inflammatory status was
to insure that the stimulus for measuring FMD was as uniform as
possible for each visit since a change in blood viscosity could
influence the shear stress of the vessel wall and therefore increase
the measured FMD, likewise elevated blood glucose has been
showed to decrease FMD response. Endothelial function was
measured using Flow Mediated Dilation (FMD) using a protocol
following current guidelines.[11,12] The participants were in-
structed to arrive for the investigation after fasting for the last
12 hours including medication. After arrival they were placed in
supine position for at least 10 minutes before initiation of
measurements. The examination room was quiet and had a
temperature of about 22uC and had subdued lighting. Measure-
ments were performed on the brachial artery of the right upper
arm approximately 10 cm above the antecubital fossae with the
pneumatic tourniquet placed distally to the ultrasound transducer
immediately below the antecubital fossae at the area of greatest
width of the forearm. The tourniquet was inflated to a pressure of
300 mm Hg for a period of 4 minutes and 45 seconds. During the
last 15 seconds of inflation and the first 15 seconds after deflation
of the tourniquet, a Doppler spectroscopy of the flow through the
brachial artery was recorded, permitting calculation of the flow
increase through the brachial artery. As a control, the flow
independent dilation (FID) was measured 10 minutes after the
measurement of FMD by administering 100 mg nitroglycerin
sublingually. Measurement of FMD and FID were given as the
relative increase in diameter in percent compared to the baseline
diameter of the brachial artery. In order to asses the possible
changes of shear stress during the study, blood samples were
analyzed for the relative content of red blood cells and
inflammatory markers (leukocytes and c-reactive protein) since
these factors usually are the most important contributors to the
viscosity of the blood.[13] The measurements were performed on
an Acuson XP10/4 ultrasound apparatus using a 7 MHz linear
transducer (L7), and the images were analyzed real time on a
Personal computer using a NI PCI-1470 frame grabber and
Vascular Image Acquisition (VIA) software.[14,15] The visits were
made on the same time of the day in order to avoid diurnal
variation of FMD.
Procurement of sprouts
The broccoli sprouts were obtained from a commercial grower
(Van Der Plass Sprouts BV, the Netherlands) and were sprouted
for 3 days. Immediately after harvesting they were refrigerated
Table 1. In and exclusion criteria for the participants.
Inclusion Criteria
N Hypertension, defined as a diastolic blood pressure of above 90 mm Hg or a systolic blood pressure of more than 140 mm Hg or in medical treatment for
hypertension.
Exclusion Criteria
N Impaired glucose tolerance, measured by an oral glucose tolerance test or diabetes according to internationally recognized criteria
N Known hypertension due to renal artery stenosis
N Hypercholesterolemia defined as a total cholesterol of more than 5 mM or statin treatment,
N Smokers
N Patients receiving vitamin K-antagonists (coumarine, marcoumar)
N Women of childbearing age with no safe method of contraception
N Pregnant or breastfeeding women
N Patients under the age of 18 at inclusion in the study
doi:10.1371/journal.pone.0012461.t001
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afterwards packaged in airtight plastic bags each containing 10
grams of dried sprouts, equivalent to 100 g fresh sprouts. The
dried sprouts had the glucosinolate content measured using
previously described methods[16,17]. In accordance with the
study by Wu et al. [8] it was attempted to construct a placebo for
the control group by freezing/thawing sprouts before drying.
However this preparation still contained large amounts of
glucosinolate. Therefore the study was conducted without
placebo treatment of the control group, which served as time-
control. Before the start of the study and after the analysis of the
glucosinolate content we did consider if it would be better to use
another type of sprouts for the control group in order to keep
participants as well as investigators blinded, We decided against
this because we were not able to provide such a placebo with taste
and smell as the broccoli sprouts, and because we were not able
to get a placebo which would be identical to the broccoli sprouts
in all aspects but the glucosinolate content.
Randomization and design
Patients were randomised to treatment with broccoli sprouts or
control in a 1:1 ratio. Treatment consisted in a daily ingestion of
10 g dried broccoli sprouts. The block size for randomization was
4. Randomization was performed by an assistant in sealed
envelopes and group allocation was blinded to the investigator.
The participants were thus unblinded with regards to their
allocation but the investigator was blinded throughout the study
to the status of the participants. Since broccoli sprouts are not
commercially available and have a much larger content of
glucoraphanin than mature broccoli, we were confident that the
control group would not ingest glucoraphanin in substantial
amounts during the study. Pre-study antihypertensive medica-
tions were maintained during the study for all participants. The
participants were given a package containing 28 bags with 10 g
dried broccoli sprouts in each, instructions were to eat the content
with one of the meals of the day, they were also instructed to
avoid eating or drinking for at least 8 hours prior to each day of
study. As part of our efforts to determine compliance we took
blood samples from the participants at each session and the
participants were informed that this also was done in order to
estimate the content of the active substances in their blood
stream. The investigator was blinded during the study and the
preliminary statistical analys, During the study the analysis of
blood samples and measurement of FMD was done immediately
after each session and the data were entered into the study
database. The investigator was unaware of the allocation of the
participants during the study. After conclusion of the study the
allocation of each participant into two groups was given the
investigator, but during this part it was still not revealed which
group had been the control and which had been the
interventional group.
Objectives and Outcomes
Following the hypothesis outlined in the introduction our
primary outcome was if we would observe an increase in FMD
in the interventional group during the intervention.Secondary
outcomes were changes in blood pressure and changes in levels
of blood cholesterol during the study in the interventional
group.
Statistical Methods
The results were analyzed using SAS software (version 9.10).
Comparisons between intervention and control group were
analysed by non-paired Student’s t-test and comparison of changes
over time for the intervention and the control group were
performed using a paired students test. Results were presented
with calculated mean values and confidence intervals for the
measurements at the different session as well as for the differences
between values in the two groups.
Table 2. Baseline characteristics of the control and interventional group.
Control Sd Range Intervention SD Range p
Male 5 n/a n/a 11 n/a 0.10
Female 15 n/a n/a 10 n/a 0.50
Age 54 10 32–67 58 9 38–77 0.23
Cigarettes(Packet years) 6.9 17 0–70 6 10.4 0–41 0.84
BMI 26.2 3.2 22–33.7 29.1 6.6 21–51 0.08
Systolic mean 158.6 20.4 132–215 158.5 20.9 121–196 0.98
Diastolic mean 98 7.8 88–115 96 10.4 80–115 0.50
Plasma Glucose 5.3 0.4 4.5–5.9 5.4 0.4 4.5–6.4 0.40
total Cholesterol 5 0.7 3.6–7.1 5.1 1 3.6–7.6 0.55
HDL 1.7 0.5 .9–2.8 1.7 0.6 1.1–3.4 0.85
LDL 2.9 1 2–4.2 3 0.8 1.7–5.1 0.32
Triglycerides 1.09 0.7 0.43–3.59 1.03 0.6 0.38–2.5 0.71
Antihypertensive drugs users users p
C03 Diuretics 4 n/a n/a 5 n/a n/a 0.77
C07 b-Blockers 2 n/a n/a 2 n/a n/a 0.96
C08 Calciumantagonists 7 n/a n/a 3 n/a n/a 0.12
C09 ACE inhibitors or ATII antagonists 8 n/a n/a 12 n/a n/a 0.27
Since all participants were non smokers at the time of the investigation, packet-years refers to years of smoking prior to the study. Antihypertensive drugs are grouped
by ATC.
doi:10.1371/journal.pone.0012461.t002
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3% difference inFMD, on this assumptionit was calculatedthat our
studywouldhavea powerof90% with 20individuals ineachgroup.
Results
Participant flow
The study enrolled 41 participants, 20 in the control group and
21 in the interventional group. In all 53 persons were screened prior
to enrollment, of these10 did not meet the enrollment criteria and 2
decided not to participate. The reason for including one more in the
interventional group was that one participant dropped out one day
after receiving the sprouts owing to the disagreeable taste of the
sprouts. One participant in the interventional group missed one visit
because of hospitalization (leg fracture). All other participants
received treatment as allocated and participated in examinations as
planned. The baseline characteristics for the participants are listed
in Table 2 and the participant flow diagram is presented in Fig. 1.
Vascular measurements
The FMD values with 95% confidence interval and p values
calculated using students test for the intervention and control group
are displayed in Table 3; overall, no significant changes occurred in
the two groups during the period of treatment. The change in mean
FMD between weeks 0 and 4 is greaterby 2.25% in the intervention
group compared with the control group. The 95% confidence
Figure 1. Consort 2001 flow diagram.
doi:10.1371/journal.pone.0012461.g001
Table 3. Development of FMD in percent during the study.
Week 0 2 4 Change 0–4
Intervention Mean 4.07 4.12 5.80 1.78
CI 2.75 to
5.39
2.93 to
5.31
3.19 to
8.41
20.95 to
4.41
Control Mean 4.08 3.60 3.56 20.52
CI 2.70 to
5.46
2.55 to
4.64
2.74 to
4.38
21.99 to
0.94
Difference Mean 20.01 0.53 2.24 2.25
CI 21.88 to
1.84
21.01 to
2.06
20.46 to
4.98
20.73 to
5.23
Mean and confidence interval (2,5–97,5%) none of the differences were
significant on the 0.05 level using Students Test.
doi:10.1371/journal.pone.0012461.t003
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FMD was slightly lower in the control groupas seen by Fig. 2, and
the average vascular diameter was slightly lower in the control
group (data not shown). Figure 2 shows boxplots of the FMD values
in the interventional as well as the controlgroup, of notice is that the
median values for the FMD in either group did not change during
the study. In order to visualize the causes for the observed changes
in the interventional group for week 0 to 4, we have in Figure 3
plotted a histogram for the distribution of changes in the FMD
values in the interventional group between week 0 and week 4.
Blood Samples
For the blood test taken simultaneously with the FMD
measurements, we have not been able to detect any differences in
thesesamples inthecourseofourstudy.Theresultsforareshown in
Table 2 and 4 We present the values at at randomization, as
baseline values. The variation we observe in these blood samples
appearedbasicallytobeofarandomnature andwewere notableto
demonstrate any systematic change during the experiment.
Development in blood pressure
Systolic, diastolic as well as mean blood pressure did not change
significantly during the study. Differences detected in the study
were related to gender and age.
Results are shown in Tables 5 and 6.
Glucosinolate content of the broccoli sprouts
The glucosinolate content of the sprouts was determined before and
after the drying and packaging had taken place in order to ensure that
the content of glucosinolates in the dried sprouts was known and to
asses the possible deterioration of the glucosinolates due to the drying.
Measurements of the concentration in the sprouts at the end of
the study were similar to those prior to the study (Table 7). The
sprouts had a glucoraphanin content of 25.968.5 mmol/g dry
Figure 2. Box plot of the FMD values for weeks 0, 2 and 4 during the study for the Control and Interventional group.
doi:10.1371/journal.pone.0012461.g002
Figure 3. Histogram of the differences in FMD between week 4
and week 0 in the interventional group.
doi:10.1371/journal.pone.0012461.g003
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weight.
Asstated in the methodssection blood samplesweredrawn at each
visit in order to determine the glucosinolate content in the blood of
the participants. Analysis of these samples did not show detectable
levels of glucosinolates or isothiocyantaes in any of the participants.
Adverse events
Apart from one participant leaving the study because of the
taste of the sprouts which made her very uncomfortable, no
adverse effects were observed during the study.
Discussion
In the current study we have tested whether dietary glucosino-
lates can improve endothelial function in patients with hyperten-
sion as it has been demonstrated in animal models.[8] Using
supplements of broccoli sprouts with preserved concentrations of
the glucosinolate glucoraphanin, we found no significant change in
endothelial function, measured twice during an investigator-
blinded 4-week treatment period. We are aware of the fact that
a change does take place in the interventional group between week
0 and week 4 even if this change is insignificant. An issue could
therefore be if this lack of significance was due to insufficient
power of the study. We find this unlikely, since, as demonstrated in
Figure 3 it is very few of the participants in the interventional
group who actually increase their peak dilation during the study.
At Figure 3 it can also be seen, that the majority of the observed
changes cluster around 0 with 75% having a change in FMD of
less than 3%, our stated minimum observable difference. If we
look at the distribution of the absolute difference in peak diameter
for week 0 and 4, we find a similar pattern with 75% having a peak
diameter difference of 0.26 mm or less, values which are very close
to the measuring uncertainty of the method. As Figure 3 shows the
mean increase in FMD and peak diameter of week four is mainly
due to two participants, who have very pronounced increases in
their response. Furthermore, the confidence interval (20.732
5.23) quoted in the results section indicates that broccoli sprouts
have an effect of at most 5% on the mean FMD. As such we find it
justified to state, that we do not observe an increase in FMD in our
study group.
During this period, we have not been able to demonstrate any
change in blood pressure, or blood samples reflecting blood lipids
or inflammatory status. This finding is at odds with experiments
carried out on spontaneously hypertensive stroke prone rats
Table 5. Development of Systolic Blood Pressure during the study.
0 2 4 Change 0–4
Intervention Mean 152.30 149.21 145.15 27.80
CI 143.10 to 161.50 141.45 to 156.97 136.57 to 153.73 219.13 to 3.53
Control Mean 145.85 148.75 144.50 20.70
CI 136.93 to 154.77 139.17 to 158.33 137.58 to 151.42 214.44 to 13.04
Difference Mean 6.45 0.46 0.65 25.80
CI 25.94 to 18.84 211.48 to 12.40 211.33 to 10.03 224.34 to 10.14
Mean and confidence interval (2,5–97,5%) none of the differences were significant on the 0.05 level using Students Test.
doi:10.1371/journal.pone.0012461.t005
Table 4. Mean, confidence intervals and p-values for selected
blood samples, p-values calculated using Students test.
Total
Cholesterol
Interven-
tion Control
Weeks mean CI 2.5 CI 97.5 mean CI 2.5 CI 97.5 p-value
0 5.08 4.62 5.53 4.95 4.65 5.24 0.62
2 5.07 4.57 5.57 4.88 4.62 5.14 0.49
4 5.04 4.55 5.53 5.06 4.76 5.36 0.94
HDL
Weeks mean CI 2.5 CI 97.5 mean CI 2.5 CI 97.5 p-value
0 1.73 1.49 1.97 1.81 1.54 2.07 0.67
2 1.67 1.40 1.94 1.73 1.50 1.96 0.72
4 1.65 1.40 1.90 1.78 1.54 2.01 0.45
LDL
Weeks mean CI 2.5 CI 97.5 mean CI 2.5 CI 97.5 p-value
0 2.76 2.29 3.22 2.78 2.51 3.04 0.94
2 2.72 2.26 3.19 2.72 2.48 2.95 0.98
4 2.89 2.49 3.28 2.80 2.53 3.06 0.70
Haemato-
chrite
Week mean CI 2.5 CI 97.5 mean CI 2.5 CI 97.5 p-value
0 0.39 0.34 0.43 0.58 0.20 0.96 0.31
2 0.41 0.39 0.42 0.40 0.39 0.41 0.17
4 0.40 0.39 0.42 0.39 0.38 0.40 0.24
doi:10.1371/journal.pone.0012461.t004
Table 6. Development of Diastolic Blood Pressure during the
study.
0 2 4 Change 0–4
Intervention Mean 89.70 90.58 88.65 21.05
CI 83.73 to
95.66
84.88 to
96.28
84.04 to
93.26
28.18 to
6.08
Control Mean 91.80 89.55 88.75 23.05
CI 86.53 to
97.07
85.32 to
93.78
84.84 to
92.66
29.12 to
3.02
Difference Mean 22.10 1.03 20.10 2.00
CI 29.80 to
5.60
25.80 to
7.91
25.95 to
5.75
27.06 to
11.06
Mean and confidence interval (2,5–97,5%) none of the differences were
significant on the 0.05 level using Students Test.
doi:10.1371/journal.pone.0012461.t006
Broccoli Hypertension
PLoS ONE | www.plosone.org 6 August 2010 | Volume 5 | Issue 8 | e12461(SHSP), which may be due to a variety of factors. The animal
study was designed to investigate if a daily dose of sprouts would
protect against the development of hypertension, while we only
studied endothelial function in patients with established hyperten-
sion. Furthermore, dosage as well as duration of treatment was
also different, as the rats were given dried sprouts from weaning
and until termination of the experiment after fourteen weeks,
which translated to a human lifespan would imply treatment form
early childhood into adolescence. Finally, hypertension is not a
well described disease entity in humans whereas the SHSP are a
distinct breed of rats characterized by their tendency to develop
hypertension and stroke.[18,19] It is therefore very likely that the
rats are much more uniform in the genetic layout which
determines their tendency to hypertension and in the mechanism
by which they develop their hypertension. In contrast the genes
determining hypertension in humans are probably heterogeneous.
It is therefore possible that the mechanism we tried to influence is
not the relevant mechanism in all humans. For cancer,
epidemiological studies suggest that in humans, the possible
beneficial effects of brassica in the diet is dependent on genetic
polymorphisms in the target population[20].
Our study has some limitations that need to be addressed. The
dose we gave was, if related to body mass, approximately 7 times
smaller than the dosage given to the rats in the study discussed
above[8], however prior to the study we tried to establish a dose
which would be tolerable to humans and decided against a larger
dose, since it was associated with gastrointestinal side effects. Our
dose is also comparable with doses given to humans in other
studies, which have demonstrated an effect of broccoli sprouts on
humans in a similar timespan.[21,22,23,24,25]
The fact that we were not able to detect glucosinolates in the
blood of the participants raises the question if lack of compliance
could be a reason for the lack of observed effect. Other studies
does indicate that the glucosinolates in the precense of myrosinase
will be transformed to isothocyanates at an early stage of
digestion[26] so this does not necessarily mean that our
participants were non compliers. However, judging from the
overall behavior of our participants and due to the fact that some
of the participants in the interventional group wrote to us to tell
how much they had liked the taste of the sprouts, we do not believe
this has been the fact. Furthermore during the study the
participants were informed of our intention of analyzing for
glucosinolates in their blood samples. Another question which
could be raised is whether the observed FMD in the two groups is
impaired or not. Indeed, the FMD measured in the individuals in
this study (total average 4.263.2) is lower than the FMD values we
have observed in groups with healthy non smoking volunteers
(5.762.4). Since other studies have presented effect on FMD after
treatment with drugs or other substances in a comparable time-
span to the 4 weeks used in our study and since an increase in gene
expression after exposure of broccoli has been observed in the
human intestine 6 hours after ingestion[21], it should be expected
to see an effect of glucosinolates on endothelial function after four
weeks of treatment.
As stated in the result section we did not find any changes in
blood lipids measured during the intervention period. This is at
odds with other experiments carried out in humans and with
similar doses of sprouts, since Murashima et al demonstrated a
decrease in total and LDL cholesterol in humans after one week of
treatment with 50 g of fresh broccoli sprouts given daily, our daily
dose had twice the glucosinolate content, comparable to 100 g
fresh sprouts. We used dried broccoli sprouts as opposed to fresh
sprouts, since other studies have shown a rather fast deterioration
of the glucosinolate content in fresh broccoli[27,28]. Our study
had a longer duration of treatment than the study by Murashima
et al., which suggests that the effect of glucosinolates on lipids may
be an early transient one or that other substances in fresh sprouts
can be attributable to the changes observed in the study of
Murahisma et al,[24] We therefore conclude that a four week
treatment of dried broccoli sprouts, given as daily doses of 10 g
does not improve endothelial function in patients with established
hypertension, and does not change serum cholesterol levels.
Further investigations are needed to elucidate if broccoli sprouts or
glucosinolates have a positive effect on endothelial function in
subgroups of hypertensive patients or other patient groups.
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